Literature DB >> 23588672

Fumarate copolymers-based membranes overlooking future transdermal delivery devices: synthesis and properties.

Magalí Pasqualone1, Tamara G Oberti, Héctor A Andreetta, M Susana Cortizo.   

Abstract

Novel copolymers of vinyl acetate and dialkylfumarates, poly(VA-co-DRF) with R = isopropyl (DIPF) or octan-2-yl (DOF), were synthesized by radical copolymerization under microwave conditions. The products were characterized by (1)H NMR and FTIR spectroscopies, size exclusion chromatography and differential scanning calorimetry. Based on these copolymers three membranes supported on polyvinyl alcohol were prepared and their morphology, swelling and mechanical properties were studied. The swelling kinetic was analyzed and interpreted in light of the Fick transport model, showing that the water transport occurs through a non-Fickian diffusion mechanism. The results show that the membrane prepared of poly(VA-co-DOF) exhibited excellent properties as potential platform for transdermal delivery system: they exhibited good tensile strength, moderated swelling and form thin and transparent films.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588672     DOI: 10.1007/s10856-013-4925-2

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  24 in total

Review 1.  Transdermal delivery of drugs for the treatment of bone diseases.

Authors:  C Ramachandran; D Fleisher
Journal:  Adv Drug Deliv Rev       Date:  2000-08-31       Impact factor: 15.470

Review 2.  Tissue engineering of bone: material and matrix considerations.

Authors:  Yusuf Khan; Michael J Yaszemski; Antonios G Mikos; Cato T Laurencin
Journal:  J Bone Joint Surg Am       Date:  2008-02       Impact factor: 5.284

3.  1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.

Authors:  Nicholas A Peppas
Journal:  J Control Release       Date:  2014-09-28       Impact factor: 9.776

4.  A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation.

Authors:  Biswajit Mukherjee; Sushmita Mahapatra; Ritu Gupta; Balaram Patra; Amit Tiwari; Priyanka Arora
Journal:  Eur J Pharm Biopharm       Date:  2005-04       Impact factor: 5.571

5.  Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin.

Authors:  So Hee Nam; Ying Ji Xu; Hyemi Nam; Geun-woo Jin; Yunseong Jeong; Songhie An; Jong-Sang Park
Journal:  Int J Pharm       Date:  2011-07-22       Impact factor: 5.875

6.  Experimental design for optimizing drug release from silicone elastomer matrix and investigation of transdermal drug delivery.

Authors:  Bergthóra S Snorradóttir; Pálmar I Gudnason; Freygardur Thorsteinsson; Már Másson
Journal:  Eur J Pharm Sci       Date:  2011-03-01       Impact factor: 4.384

7.  Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering.

Authors:  Juan Manuel Fernandez; M Silvina Molinuevo; M Susana Cortizo; Ana M Cortizo
Journal:  J Tissue Eng Regen Med       Date:  2011-02-10       Impact factor: 3.963

8.  Novel biomaterials for bisphosphonate delivery.

Authors:  Solen Josse; Corinne Faucheux; A Soueidan; Gaël Grimandi; Dominique Massiot; Bruno Alonso; Pascal Janvier; Samia Laïb; Paul Pilet; Olivier Gauthier; Guy Daculsi; J Jérôme Guicheux; Bruno Bujoli; Jean-Michel Bouler
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

Review 9.  Bisphosphonates: a review of their pharmacokinetic properties.

Authors:  J H Lin
Journal:  Bone       Date:  1996-02       Impact factor: 4.398

10.  The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.

Authors:  Ahyoung Choi; Hyesil Gang; Inkoo Chun; Hyesun Gwak
Journal:  Int J Pharm       Date:  2008-02-03       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.